{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,2]],"date-time":"2026-08-02T15:12:40Z","timestamp":1785683560626,"version":"3.56.0"},"reference-count":28,"publisher":"Oxford University Press (OUP)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,3,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objectives:<\/jats:title>\n                  <jats:p>To study the diagnostic value of BCL2 rearrangement in follicle center lymphoma (FCL) presenting as primary skin lesions, evaluate its prevalence and the prognostic value in primary cutaneous FCL (PCFCL), and assess prognostic factors in PCFCL.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods:<\/jats:title>\n                  <jats:p>Fifty-three patients with a cutaneous presentation of FCL without a history of nodal lymphoma were selected retrospectively. Clinical and histologic data were collected together with staging and follow-up data. A fluorescence in situ hybridization (FISH) test for BCL2 split probes was performed on skin biopsy specimens.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results:<\/jats:title>\n                  <jats:p>Initial staging procedures identified 47 PCFCLs and six cases of secondary skin involvement of FCL (SSIFCL). FISH detected seven cases carrying a BCL2 rearrangement: four (8.5%) of 47 PCFCLs and three (50%) of six SSIFCLs. These seven cases coexpressed BCL2 and CD10. In PCFCL, cutaneous relapse rate was 42.6%. A small\/medium centrocytic cell population was associated with a higher probability of skin relapse in univariate (P = .008) and multivariate (P = .028) analysis, and BCL2 rearrangement detection was associated with secondary extracutaneous spreading (P = .05).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions:<\/jats:title>\n                  <jats:p>We observed that BCL2 rearrangement in PCFCL is rare, associated with initial positivity of staging (diagnostic value) or with secondary extracutaneous spreading (prognostic value). In selected cases with BCL2-CD10 coexpression, FISH testing could detect patients with poor outcome and require closer monitoring.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1309\/ajcp4subr4npsptn","type":"journal-article","created":{"date-parts":[[2015,2,26]],"date-time":"2015-02-26T22:01:49Z","timestamp":1424988109000},"page":"362-373","source":"Crossref","is-referenced-by-count":44,"title":["Diagnostic and Prognostic Value of <i>BCL2<\/i> Rearrangement in 53 Patients With Follicular Lymphoma Presenting as Primary Skin Lesions"],"prefix":"10.1093","volume":"143","author":[{"given":"Anne","family":"Pham-Ledard","sequence":"first","affiliation":[{"name":"1Dermatology Department, CHU de Bordeaux, Bordeaux, France"},{"name":"2EA2406 Histology and Molecular Pathology of Tumours, University of Bordeaux, Bordeaux, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Cowppli-Bony","sequence":"additional","affiliation":[{"name":"3Clinical Epidemiology Unit, CHU de Bordeaux, Bordeaux, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ad\u00e9la\u00efde","family":"Doussau","sequence":"additional","affiliation":[{"name":"3Clinical Epidemiology Unit, CHU de Bordeaux, Bordeaux, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Prochazkova-Carlotti","sequence":"additional","affiliation":[{"name":"2EA2406 Histology and Molecular Pathology of Tumours, University of Bordeaux, Bordeaux, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elodie","family":"Laharanne","sequence":"additional","affiliation":[{"name":"2EA2406 Histology and Molecular Pathology of Tumours, University of Bordeaux, Bordeaux, France"},{"name":"4Pathology Department, CHU de Bordeaux, Bordeaux, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Jouary","sequence":"additional","affiliation":[{"name":"1Dermatology Department, CHU de Bordeaux, Bordeaux, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc-Antoine","family":"Belaud-Rotureau","sequence":"additional","affiliation":[{"name":"2EA2406 Histology and Molecular Pathology of Tumours, University of Bordeaux, Bordeaux, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e9atrice","family":"Vergier","sequence":"additional","affiliation":[{"name":"2EA2406 Histology and Molecular Pathology of Tumours, University of Bordeaux, Bordeaux, France"},{"name":"4Pathology Department, CHU de Bordeaux, Bordeaux, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Philippe","family":"Merlio","sequence":"additional","affiliation":[{"name":"2EA2406 Histology and Molecular Pathology of Tumours, University of Bordeaux, Bordeaux, France"},{"name":"4Pathology Department, CHU de Bordeaux, Bordeaux, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Beylot-Barry","sequence":"additional","affiliation":[{"name":"1Dermatology Department, CHU de Bordeaux, Bordeaux, France"},{"name":"2EA2406 Histology and Molecular Pathology of Tumours, University of Bordeaux, Bordeaux, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2015,3,1]]},"reference":[{"key":"2023012004412916800_b1-1430362","doi-asserted-by":"crossref","first-page":"3768","DOI":"10.1182\/blood-2004-09-3502","article-title":"WHO-EORTC classification for cutaneous lymphomas","volume":"105","author":"Willemze","year":"2005","journal-title":"Blood"},{"key":"2023012004412916800_b2-1430362","volume-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","author":"Swerdlow","year":"2008"},{"key":"2023012004412916800_b3-1430362","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.jaad.2013.06.011","article-title":"Primary cutaneous B-cell lymphomas, part I: clinical features, diagnosis, and classification","volume":"69","author":"Su\u00e1rez","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"2023012004412916800_b4-1430362","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1200\/JCO.2006.09.6396","article-title":"Reclassification of 300 primary cutaneous B-cell lymphomas according to the new WHO-EORTC classification for cutaneous lymphomas: comparison with previous classifications and identification of prognostic markers","volume":"25","author":"Senff","year":"2007","journal-title":"J Clin Oncol"},{"key":"2023012004412916800_b5-1430362","doi-asserted-by":"crossref","first-page":"3602","DOI":"10.1200\/JCO.2001.19.16.3602","article-title":"Prognostic factors in primary cutaneous large B-cell lymphomas: a European multicenter study","volume":"19","author":"Grange","year":"2001","journal-title":"J Clin Oncol"},{"key":"2023012004412916800_b6-1430362","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1182\/blood-2008-04-152850","article-title":"European Organization for Research and Treatment of Cancer and International Society for Cutaneous Lymphoma consensus recommendations for the management of cutaneous B-cell lymphomas","volume":"112","author":"Senff","year":"2008","journal-title":"Blood"},{"key":"2023012004412916800_b7-1430362","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1097\/01.pas.0000126775.27698.6e","article-title":"Neoplastic cells do not carry bcl2-JH rearrangements detected in a subset of primary cutaneous follicle center B-cell lymphomas","volume":"28","author":"Vergier","year":"2004","journal-title":"Am J Surg Pathol"},{"key":"2023012004412916800_b8-1430362","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1200\/JCO.1998.16.6.2080","article-title":"bcl-2 Protein expression in primary cutaneous large B-cell lymphoma is site-related","volume":"16","author":"Geelen","year":"1998","journal-title":"J Clin Oncol"},{"key":"2023012004412916800_b9-1430362","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1046\/j.1365-2133.2001.04128.x","article-title":"Absence of the t(14;18) chromosomal translocation in primary cutaneous B-cell lymphoma","volume":"144","author":"Child","year":"2001","journal-title":"Br J Dermatol"},{"key":"2023012004412916800_b10-1430362","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1097\/00000478-200604000-00015","article-title":"Molecular cytogenetic evidence of t(14;18)(IGH;BCL2) in a substantial proportion of primary cutaneous follicle center lymphomas","volume":"30","author":"Streubel","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"2023012004412916800_b11-1430362","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1038\/modpathol.3880398","article-title":"Cutaneous follicle center lymphoma: a clinicopathologic study of 19 cases","volume":"14","author":"Aguilera","year":"2001","journal-title":"Mod Pathol"},{"key":"2023012004412916800_b12-1430362","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1309\/2TJU-DNLQ-5JBA-AB4T","article-title":"The t(14;18) and bcl-2 expression are present in a subset of primary cutaneous follicular lymphoma: association with lower grade","volume":"118","author":"Lawnicki","year":"2002","journal-title":"Am J Clin Pathol"},{"key":"2023012004412916800_b13-1430362","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1200\/JCO.2002.20.3.647","article-title":"Primary cutaneous follicular lymphoma: an assessment of clinical, histopathologic, immunophenotypic, and molecular features","volume":"20","author":"Mirza","year":"2002","journal-title":"J Clin Oncol"},{"key":"2023012004412916800_b14-1430362","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/01.pas.0000146015.22624.c7","article-title":"Clinicopathologic, immunophenotypic, and molecular cytogenetic fluorescence in situ hybridization analysis of primary and secondary cutaneous follicular lymphomas","volume":"29","author":"Kim","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"2023012004412916800_b15-1430362","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1182\/blood-2006-10-054601","article-title":"TNM classification system for primary cutaneous lymphomas other than mycosis fungoides and S\u00e9zary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the Cutaneous Lymphoma Task Force of the European Organization of Research and Treatment of Cancer (EORTC)","volume":"110","author":"Kim","year":"2007","journal-title":"Blood"},{"key":"2023012004412916800_b16-1430362","first-page":"1147","article-title":"Contribution of histopathologic and molecular analyses to the diagnosis of cutaneous B-cell infiltrates","volume":"9","author":"Dubus","year":"1996","journal-title":"Mod Pathol"},{"key":"2023012004412916800_b17-1430362","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.humpath.2006.08.022","article-title":"Interphase fluorescence in situ hybridization is more sensitive than BIOMED-2 polymerase chain reaction protocol in detecting IGH-BCL2 rearrangement in both fixed and frozen lymph node with follicular lymphoma","volume":"38","author":"Belaud-Rotureau","year":"2007","journal-title":"Hum Pathol"},{"key":"2023012004412916800_b18-1430362","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1038\/sj.leu.2403202","article-title":"Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98\u20133936","volume":"17","author":"Van Dongen","year":"2003","journal-title":"Leukemia"},{"key":"2023012004412916800_b19-1430362","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/j.1365-2559.2006.02501.x","article-title":"BCL2 gene abnormalities define distinct clinical subsets of follicular lymphoma","volume":"49","author":"Goodlad","year":"2006","journal-title":"Histopathology"},{"key":"2023012004412916800_b20-1430362","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1002\/sim.4479","article-title":"General joint frailty model for recurrent event data with a dependent terminal event: application to follicular lymphoma data","volume":"31","author":"Mazroui","year":"2012","journal-title":"Stat Med"},{"key":"2023012004412916800_b21-1430362","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1097\/00000478-200106000-00004","article-title":"Cutaneous B-cell lymphomas of follicular and marginal zone types: use of Bcl-6, CD10, Bcl-2, and CD21 in differential diagnosis and classification","volume":"25","author":"De Leval","year":"2001","journal-title":"Am J Surg Pathol"},{"key":"2023012004412916800_b22-1430362","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1111\/j.1365-2133.2003.05649.x","article-title":"Bcl-2, Bcl-6 and CD10 expression in cutaneous B-cell lymphoma: further support for a follicle centre cell origin and differential diagnostic significance","volume":"149","author":"Hoefnagel","year":"2003","journal-title":"Br J Dermatol"},{"key":"2023012004412916800_b23-1430362","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1309\/AJCPNLC9NC9WTQYY","article-title":"Cutaneous B-cell lymphoproliferative disorders: report of the 2011 Society for Hematopathology\/European Association for Haematopathology workshop","volume":"139","author":"Swerdlow","year":"2013","journal-title":"Am J Clin Pathol"},{"key":"2023012004412916800_b24-1430362","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1684\/ejd.2009.0633","article-title":"Routine bone marrow biopsy in the initial evaluation of primary cutaneous B-cell lymphoma does not appear justified","volume":"19","author":"Quereux","year":"2009","journal-title":"Eur J Dermatol"},{"key":"2023012004412916800_b25-1430362","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/j.1365-2141.2008.07159.x","article-title":"Results of bone marrow examination in 275 patients with histological features that suggest an indolent type of cutaneous B-cell lymphoma","volume":"142","author":"Senff","year":"2008","journal-title":"Br J Haematol"},{"key":"2023012004412916800_b26-1430362","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1093\/annonc\/mds517","article-title":"ESMO guidelines consensus conference on malignant lymphoma 2011 part 1: diffuse large B-cell lymphoma (DLBCL), follicular lymphoma (FL) and chronic lymphocytic leukemia (CLL)","volume":"24","author":"Ghielmini","year":"2013","journal-title":"Ann Oncol"},{"key":"2023012004412916800_b27-1430362","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1158\/0008-5472.CAN-03-3604","article-title":"Characterization of the t(14;18) BCL2-IGH translocation in farmers occupationally exposed to pesticides","volume":"64","author":"Roulland","year":"2004","journal-title":"Cancer Res"},{"key":"2023012004412916800_b28-1430362","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1200\/JCO.2005.03.6285","article-title":"Prognostic factors in primary cutaneous B-cell lymphoma: the Italian Study Group for Cutaneous Lymphomas","volume":"24","author":"Zinzani","year":"2006","journal-title":"J Clin Oncol"}],"container-title":["American Journal of Clinical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ajcp\/article-pdf\/143\/3\/362\/48791307\/ajcp_143_3_362.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajcp\/article-pdf\/143\/3\/362\/48791307\/ajcp_143_3_362.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,20]],"date-time":"2023-01-20T04:44:13Z","timestamp":1674189853000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajcp\/article\/143\/3\/362\/1766557"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3,1]]},"references-count":28,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2015,3,1]]},"published-print":{"date-parts":[[2015,3,1]]}},"URL":"https:\/\/doi.org\/10.1309\/ajcp4subr4npsptn","relation":{},"ISSN":["1943-7722","0002-9173"],"issn-type":[{"value":"1943-7722","type":"electronic"},{"value":"0002-9173","type":"print"}],"subject":[],"published-other":{"date-parts":[[2015,3,1]]},"published":{"date-parts":[[2015,3,1]]}}}